Shilpa Medicare partners with Orion for Recombinant Human Albumin for European market
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Twelve hospitals across India will be part of the network which will support the trial in India
Donor privilege cards given to the families of all the donors from across Karnataka as a token of appreciation
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
The new centre will comprise a team of 50 highly experienced specialists
Subscribe To Our Newsletter & Stay Updated